CHINA PHARMA HOLDINGS, INC. Inventory
CHINA PHARMA HOLDINGS, INC. (CPHI) had Inventory of $1.36 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-14
- 2026-06-30: Inventory, Net $1.36M.
- 2026-03-31: Inventory, Net $1.50M.
- 2025-12-31: Inventory, Net $1.62M.
- 2025-09-30: Inventory, Net $1.65M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $1.36M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.50M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.62M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.65M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.68M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.98M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.27M 10-K · filed 2026-04-01 | |
| 2024-09-30 | $2.50M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.82M 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $3.73M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $3.77M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $3.91M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $3.76M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $2.95M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.89M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.53M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $3.91M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.95M 10-Q · filed 2023-05-12 | $3.34M 10-K · filed 2022-03-30 |
| 2021-09-30 | $3.07M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $2.98M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $3.66M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $3.71M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $3.51M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $3.85M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $3.63M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $3.59M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $3.97M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $4.39M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $4.93M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $5.05M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $6.10M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $6.38M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $6.36M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $6.41M 10-K · filed 2019-03-28 | |
| 2017-09-30 | $6.83M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $7.26M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $6.99M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $7.31M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $8.57M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $8.94M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $9.92M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $9.66M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $12.29M 10-Q · filed 2015-12-28 | |
| 2015-06-30 | $13.62M 10-Q · filed 2015-12-28 | |
| 2015-03-31 | $15.35M 10-Q · filed 2015-12-28 | |
| 2014-12-31 | $15.32M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $19.01M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $20.96M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $22.89M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $24.68M 10-K · filed 2015-12-28 | |
| 2013-09-30 | $32.64M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $33.71M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $33.26M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $36.36M 10-K · filed 2014-03-20 | |
| 2012-09-30 | $37.81M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $36.40M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $34.32M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $30.38M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $26.62M 10-Q/A · filed 2012-03-06 | |
| 2011-06-30 | $23.98M 10-Q/A · filed 2011-09-06 | |
| 2010-12-31 | $20.39M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |